Generic

Bondrix 150 contains Ibandronic Acid 150 mg, a bisphosphonate used to treat and prevent osteoporosis in postmenopausal women.

Description

Bondrix 150 is an osteoporosis treatment manufactured by The IBN SINA Pharmaceutical Industry Ltd. It inhibits bone resorption and helps increase bone density, reducing the risk of fractures in postmenopausal women.

Benefits

This medication strengthens bones, reduces bone loss, and prevents fractures caused by osteoporosis. It is particularly effective in postmenopausal women with low bone mass or a history of osteoporotic fractures.

Ingredients

Each tablet contains 150 mg of Ibandronic Acid, which belongs to the bisphosphonate class and helps slow down bone breakdown while maintaining bone strength.

Uses and Doses

The recommended dose is one 150 mg tablet once a month, preferably on the same date. The tablet must be taken at least 60 minutes before the first meal, beverage (except water), or other medications. If a dose is missed, take it the next morning unless the next scheduled dose is within 7 days.

Side Effects

Common side effects include nausea, diarrhea, stomach pain, dyspepsia, muscle pain, headaches, and dizziness. If not taken correctly, esophageal irritation or ulcers may occur in rare cases.

How to Use

Swallow the tablet whole with a full glass of plain water while sitting or standing upright. Do not chew or suck the tablet. Avoid lying down for at least 60 minutes after taking the medication.

Pregnancy & Lactation

Bondrix 150 is not recommended during pregnancy or breastfeeding due to potential risks to the fetus and limited safety data. Women of childbearing age should use contraception while taking this medication.

Precautions and Warnings

Patients with uncorrected hypocalcemia, esophageal disorders, or those who cannot sit or stand upright for at least 60 minutes should avoid this medication. It should be used cautiously in patients with renal impairment or gastrointestinal disorders.

Safety Information

Please do not take this medication with calcium, iron, or magnesium supplements, as they can interfere with absorption. Avoid alcohol and smoking to improve bone health. If you experience severe heartburn or swallowing difficulties, discontinue use and consult a doctor.

Indications

Bondrix 150 is indicated for the treatment and prevention of osteoporosis in postmenopausal women to reduce the risk of fractures, particularly in the spine and hips.

Pharmacology

Ibandronic Acid is a potent bisphosphonate that inhibits bone resorption by binding to hydroxyapatite in bone tissue. It selectively targets osteoclast activity, reducing excessive bone breakdown while maintaining bone formation.

Therapeutic Class

Bondrix 150 belongs to the bisphosphonate drug class, used to treat osteoporosis and related bone diseases.

Storage Conditions

Store below 30°C in a dry place, away from moisture and direct sunlight. Keep out of reach of children.

FAQ

1. Can Bondrix 150 be taken with food?
   No, it must be taken on an empty stomach for at least 60 minutes before eating or drinking anything other than water.
2. What happens if I miss a dose?
   If more than seven days remain before the next scheduled dose, take it the next morning. Otherwise, wait until the next scheduled dose.
3. Does Bondrix 150 cause stomach irritation?
   If not taken correctly, it may cause esophageal irritation. Always take it with water and remain upright for at least an hour after taking it.

Disclaimer

This information is for educational purposes only. Always consult a doctor before starting or stopping any medication.

Keywords: Bondrix 150, Ibandronic Acid, osteoporosis treatment, bone density improvement, fracture prevention, postmenopausal bone health, bisphosphonate medication, bone resorption inhibitor, osteoporosis medication, calcium metabolism, bone strength support, IBN SINA Pharmaceuticals, brittle bone treatment, monthly osteoporosis pill, spine fracture prevention, hip fracture prevention, bone health supplement, skeletal health, best osteoporosis medication, bone disease treatment.